CT186 / 14 - A first-in-human phase 1 dose-escalation and expansion study of intratumoral oncolytic reovirus (RC402) as a monotherapy or in combination with pembrolizumab in advanced solid tumors,
This trial is due to present at the AACR 24 in the same segment as CF33- NHIS, it's been around a while and very much a competitor,
also of interest when you look up the presentation about CF33 no Yuman or Chong on the list. P Woodard and J Byon seem the senior ones.
Clinical trial abstracts are under embargo and will be released at 3:00 PM ET on Friday, April 5.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-12814
-
- There are more pages in this discussion • 2,484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $507.0M |
Open | High | Low | Value | Volume |
7.3¢ | 8.1¢ | 6.7¢ | $14.30M | 190.4M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6516 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1789216 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 148443 | 0.068 |
16 | 1018563 | 0.067 |
19 | 2127092 | 0.066 |
22 | 2232249 | 0.065 |
9 | 3572475 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1732945 | 18 |
0.070 | 705222 | 8 |
0.071 | 2263995 | 11 |
0.072 | 160000 | 3 |
0.073 | 1405079 | 7 |
Last trade - 15.46pm 02/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |